alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
18 Office of Local Defense Community Cooperation — Defense Spending by Territory, FY 2022

, DEFENSE CONTRACTS

DEFENSE PERSONNEL

By Type

By Service

Top Defense Contractors (M = millions) 

Austal $748.1 M

Northrop Grumman $692.6 M

Boeing $657.5 M

M1 Support Services $539.4 M

Torch Technologies $504.8 M

SAIC $500.4 M

Lockheed Martin $462.6 M

Parsons Corp. $274.9 M

Defense Systems and Solutions $249.0 M

Radiance Technologies, Inc. $219.6 M

Contract Awards Performed (By Fiscal Year, billions)

ALABAMA

Allocations, By Type

Allocations, By Service

$3.5 BILLION

TOTAL PAYROLL

49,895

TOTAL PERSONNEL

Top Defense Personnel Locations

County Active 

Duty

Civilian National 

Guard

Reserve Total

Madison 683 13,856 415 684 15,638

Montgomery 2,646 3,145 2,740 2,055 10,586

Dale 3,314 2,220 28 155 5,717

Calhoun 42 3,024 947 308 4,321

Jefferson 267 355 1,942 1,582 4,146

Mobile 58 814 694 655 2,221

Tuscaloosa 23 92 269 241 625

Lee 68 24 172 346 610

Houston ND 37 312 76 ND

Coffee ND 142 264 0 ND

Construction: 2% Research and

Development: 29%

Service: 39%

Supplies and

Equipment: 31% 

Active Duty: 15%

Civilian: 48%

National 

Guard: 24%

Reserve: 13%

Army

Navy/Marines

Air Force

Other Defense

51%

12%

11%

26%

Army

Navy/Marines

Air Force

Other Defense

71%

2%

18%

8%

$5.1

$8.0 $7.3

$10.6 $9.8 $9.2

$10.6 

FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22

#12 #8 2.5% $2,750 #12 #13 #18 #12

$14.0 B SPENT 

IN STATE

5.0% OF 

STATE GDP

OF TOTAL U.S. 

DEFENSE SPENDING

PER 

RESIDENT

$10.3 B CONTRACT 

SPENDING

49,895 NUMBER 

OF PERSONNEL

$3.5 B PERSONNEL 

SPENDING

$231.7 M GRANT 

SPENDING

$10.3
Office of Local Defense Community Cooperation — Defense Spending by State, FY 2022

AF Active AF Guard AF Reserve Army Active Army Guard Army Reserve MC Active Navy Active WHS

Madison

Morgan

Calhoun

Lee

Dale

FISCAL YEAR 2018

TOP DEFENSE PERSONNEL SPENDING LOCATIONS

Madison

Morgan

Calhoun

Jefferson

Tuscaloosa Shelby

Montgomery

Dale

FISCAL YEAR 2018 ALABAMA

TOP DEFENSE CONTRACT SPENDING LOCATIONS (M = millions, B = billions) (M=millions) (M=millions)

FISCAL YEAR 2022

Madison

Dale

Mobile

Montgomery

Calhoun

Talladega

Tuscaloosa

Jefferson

Morgan

Shelby

(M = millions, B = billion)

$7.3 B

$884.0 M

$861.5 M

$483.7 M

$249.6 M

$75.4 M

$68.4 M

$59.3 M

$42.0 M

$28.9 M

Madison

Montgomery

Dale

Calhoun

Jefferson

Mobile

Lee

Tuscaloosa

Coffee

Morgan

$1.7 B

$644.6 M

$437.9 M

$226.8 M

$163.4 M

$101.7 M

$25.8 M

$18.4 M

$15.9 M

$10.5 M

Jefferson

Tuscaloosa

Montgomery

Talladega

Mobile

Mobile

Coffee

19
STATE of North Carolina v. Ward Lee STATON.

No. 96P05.

Supreme Court of North Carolina.

March 3, 2005.

Ward Lee Staton, Pro Se.

*846Robert R. Gelblum, Assistant Attorney General, Thomas J. Keith, District Attorney, for State of NC.

*ORDER*

Upon consideration of the petition filed on the 9th day of February 2005 by Defendant in this matter for discretionary review of the decision of the North Carolina Court of Appeals pursuant to G.S. 7A-31, the following order was entered and is hereby certified to the North Carolina Court of Appeals:

"Dismissed by order of the Court in conference, this the 3rd day of March 2005."
<PAGE>   1
                                  EXHIBIT 23.1

                         CONSENT OF INDEPENDENT AUDITORS


We consent to the incorporation by reference in Registration Statements Form S-8
(No. 333-31820) and Form S-8 (No. 333-43412), pertaining to the HealthTronics,
Inc. Stock Option Plan of our report dated February 3, 2001, with respect to the
consolidated financial statements of HealthTronics, Inc. and Subsidiaries
included in this Annual Report (Form 10-KSB) for the year ended December 31,
2000.


Atlanta, Georgia

March 23, 2001

                                                           /s/ Ernst & Young LLP


                                      F-33
STATE of North Carolina v. Alphonzo PEARCY, Jr.

No. 284P05.

Supreme Court of North Carolina.

June 30, 2005.

Alphonzo Pearcy, Jr., Pro Se.

*233A. Pluchos, Assistant Attorney General, Ronald L. Moore, District Attorney, for State of NC.

*ORDER*

Upon consideration of the petition filed on the 27th day of May 2005 by Defendant in this matter for discretionary review of the decision of the North Carolina Court of Appeals pursuant to G.S. 7A-31, the following order was entered and is hereby certified to the North Carolina Court of Appeals:

"Denied by order of the Court in conference, this the 30th day of June 2005."
I 

110TH CONGRESS 

2D SESSION H. R. 5152 

To authorize assistance for ethnic and religious minorities in Russia, Ukraine, 

and Belarus. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 29, 2008 

Mr. KIRK (for himself, Mr. KLEIN of Florida, Mr. CROWLEY, and Ms. BERKLEY) introduced the following bill; which was referred to the Committee 

on Foreign Affairs 

A BILL 

To authorize assistance for ethnic and religious minorities 

in Russia, Ukraine, and Belarus. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. 

4 This Act may be cited as the ‘‘Former Soviet Union 

5 Minority Relief Act of 2008’’. 

6 SEC. 2. AUTHORIZATION OF ASSISTANCE FOR ETHNIC AND 

7 RELIGIOUS MINORITIES IN RUSSIA, UKRAINE, 

8 AND BELARUS. 

9 (a) HUMANITARIAN ASSISTANCE.—There is author10 ized to be appropriated to the President $10,000,000 for 


pwalker on PROD1PC71 with BILLS
2 

•HR 5152 IH

1 fiscal year 2009 for the provision of humanitarian assist2 ance for ethnic and religious minorities in Russia, 

3 Ukraine, and Belarus. 

4 (b) HATE CRIME PREVENTION AND RULE OF LAW

5 ASSISTANCE.—There is authorized to be appropriated to 

6 the President $40,000,000 for fiscal year 2009 for the 

7 provision of assistance to prevent and respond to hate 

8 crimes and carry out rule of law initiatives in Russia, 

9 Ukraine, and Belarus. 

10 (c) DEMOCRACY PROMOTION ASSISTANCE.—There is 

11 authorized to be appropriated to the President 

12 $40,000,000 for fiscal year 2009 for the provision of as13 sistance to promote democracy in Russia, Ukraine, and 

14 Belarus. 

15 (d) BROADCASTING ASSISTANCE.—There is author16 ized to be appropriated to the President $25,000,000 for 

17 fiscal year 2009 for international broadcasting activities 

18 for Russia, Ukraine, and Belarus. 

19 (e) RESETTLEMENT ASSISTANCE.—There is author20 ized to be appropriated to the President $10,000,000 for 

21 fiscal year 2009 for the provision of assistance for resettle22 ment of ethnic and religious minorities in Russia, Ukraine, 

23 and Belarus. 

24 (f) ADDITIONAL REQUIREMENTS.—Amounts author25 ized to be appropriated under this section are in addition 


pwalker on PROD1PC71 with BILLS
3 

•HR 5152 IH

1 to any other amounts authorized to be appropriated for 

2 such purposes and are authorized to remain available until 

3 expended. 

Æ 


pwalker on PROD1PC71 with BILLS
STATE v. THOMAS

No. COA04-1239

Court of Appeals of North Carolina.

Filed May 3, 2005.

Certification Date May 23, 2005.

Appeal from the Forsyth (03CRS53858).

Case reported without published opinion. Remanded for resentencing.
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5397 Introduced in House (IH)]

110th CONGRESS
  2d Session
                                H. R. 5397

     To suspend temporarily the duty on certain battery assemblies.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 12, 2008

  Mr. Hodes introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
     To suspend temporarily the duty on certain battery assemblies.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. CERTAIN BATTERY ASSEMBLIES.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``      9902.01.00       Battery assembly    Free         No change        No change        On or before 12/ ''.
                          containing Nickel                                                  31/2011.......
                          Metal Hydride or
                          Lithium-ion
                          storage batteries
                          designed for use
                          in two-wheeled,
                          electrically
                          powered
                          transportation
                          devices balanced
                          by gyroscope
                          sensors and
                          onboard
                          microprocessors
                          with two
                          independent non-
                          tandem wheels, of
                          heading 8711
                          (provided for in
                          subheading
                          8507.80.80)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to articles entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5341 Introduced in House (IH)]

110th CONGRESS
  2d Session
                                H. R. 5341

    To extend the temporary suspension of duty on Gibberellic Acid.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 12, 2008

 Mrs. Biggert introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
    To extend the temporary suspension of duty on Gibberellic Acid.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. GIBBERELLIC ACID.

    (a) In General.--Heading 9902.22.95 of the Harmonized Tariff 
Schedule of the United States (relating to Gibberellic Acid) is amended 
by striking the date in the effective period column and inserting ``12/
31/2011''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
EXHIBIT 32.2

                                  CERTIFICATION
                           Pursuant to 18 U.S.C. 1350
                 (Section 906 of the Sarbanes-Oxley Act of 2002)


In connection  with the Quarterly  Report on Form 10-QSB/A of ZHONGPIN INC. (the
"Company") for the quarter ended December 31, 2005, as filed with the Securities
and Exchange Commission on the date hereof (the "Report"),  Yuanmei Ma, as Chief
Financial  Officer  of the  Company,  hereby  certifies,  pursuant  to 18 U.S.C.
ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002, that:

        (1)     The Report fully complies with the requirements of Section 13(a)
                or 15(d) of the Securities Exchange Act of 1934; and

        (2)     The information  contained in the Report fairly presents, in all
                material  respects,  the  financial  condition  and  results  of
                operations of the Company.


Date:   September 14, 2006               By: /s/ Yuanmei Ma
                                             -----------------------------------
                                             Yuanmei Ma
                                             Chief Financial Officer



--------------------------------------------------------------------------------

        This  certification  accompanies  each Report pursuant to ss. 906 of the
Sarbanes-Oxley  Act of 2002 and shall not,  except to the extent required by the
Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of ss.18
of the Securities Exchange Act of 1934, as amended.

        A signed original of this written statement  required by Section 906 has
been  provided to the Company and will be retained by the Company and  furnished
to the Securities and Exchange Commission or its staff upon request.
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H.R. 521 Enrolled Bill (ENR)]

        H.R.521

                       One Hundred Tenth Congress

                                 of the

                        United States of America

                          AT THE FIRST SESSION

          Begun and held at the City of Washington on Thursday,
            the fourth day of January, two thousand and seven

                                 An Act

 
To designate the facility of the United States Postal Service located at 
  2633 11th Street in Rock Island, Illinois, as the ``Lane Evans Post 
                           Office Building''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,
SECTION 1. LANE EVANS POST OFFICE BUILDING.
    (a) Designation.--The facility of the United States Postal Service 
located at 2633 11th Street in Rock Island, Illinois, shall be known 
and designated as the ``Lane Evans Post Office Building''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``Lane Evans 
Post Office Building''.

                               Speaker of the House of Representatives.

                            Vice President of the United States and    
                                               President of the Senate.
```
EXHIBIT 11

                         ACNIELSEN CORPORATION
            COMPUTATION OF EARNINGS PER SHARE OF COMMON STOCK
                         ON A DILUTED BASIS (a)

<TABLE>
<CAPTION>

Dollar Amounts in Millions, Except Per Share Data                                         1998           1997           1996
                                                                                          ----           ----           ----
                                                                                          (Average share data in thousands)
<S>                                                                                     <C>            <C>            <C>

Weighted-average number of common shares outstanding                                    57,236         57,139         56,712
Dilutive effect of shares issuable as of year-end under stock option plans               2,010            976            243
Adjustment of shares applicable to stock options and stock appreciation rights
   exercised during the year                                                               588            254             27
                                                                                 ============== ============== ==============
Weighted average number of shares on a diluted basis                                    59,834         58,369         56,982
                                                                                 ============== ============== ==============

                                                                                 ============== ============== ==============
Net Income                                                                               $57.2          $35.9          $15.8
                                                                                 ============== ============== ==============

                                                                                 ============== ============== ==============
Earnings per share of common stock on a diluted basis                                     $.96           $.62           $.28
                                                                                 ============== ============== ==============

<FN>
(a) All periods prior to November 1, 1996 reflect the adjusted  share and option
activity of The Dun and Bradstreet  Corporation.  Options to purchase  1,309,000
shares  of common  stock at share  prices  ranging  from  $26.19  to $27.75  and
1,864,788  shares of common  stock at prices  ranging  from $16.08 to $17.05 per
share were outstanding at the end of the years 1998 and 1996, respectively,  but
were not  included  in the  computation  of diluted  EPS  because  the  options'
exercise price was greater than the average market price of the common shares.
</FN>
</TABLE>
STATE v. OWENS.

No. COA05-128.

North Carolina Court of Appeals.

Filed December 20, 2005.

Certification Date January 9, 2006.

Appeal from Forsyth (04CRS59923)

Case without published opinion. No error.
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<EXCHANGE-RATE>                                      1
<CASH>                                           7,979
<SECURITIES>                                         0
<RECEIVABLES>                                   50,377
<ALLOWANCES>                                     1,637
<INVENTORY>                                    169,883
<CURRENT-ASSETS>                               247,114
<PP&E>                                          97,408
<DEPRECIATION>                                  16,362
<TOTAL-ASSETS>                                 609,169
<CURRENT-LIABILITIES>                           82,817
<BONDS>                                        210,520
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                     317,465
<TOTAL-LIABILITY-AND-EQUITY>                   609,169
<SALES>                                        653,032
<TOTAL-REVENUES>                               661,293
<CGS>                                          517,571
<TOTAL-COSTS>                                  534,229
<OTHER-EXPENSES>                                72,411
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              13,302
<INCOME-PRETAX>                                 41,351
<INCOME-TAX>                                    18,567
<INCOME-CONTINUING>                             22,784
<DISCONTINUED>                                   5,000
<EXTRAORDINARY>                                    851
<CHANGES>                                            0
<NET-INCOME>                                    16,933
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
---

Exhibit 13.a

CERTIFICATION PURSUANT TO 
    18 U.S.C. SECTION 1350, 
    AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Paul Averback, President and CEO of Nymox Pharmaceutical Corporation, do hereby certify that, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the information contained in the Annual Report on Form 20-F for the year ended December 31, 2010 of Nymox Pharmaceutical Corporation and filed with the Securities and Exchange Commission, fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934 and the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Nymox Pharmaceutical Corporation. Date: March 15, 2011 /s/ Paul Averback, MDPaul Averback, MDPresident and Chief Executive OfficerNymox Pharmaceutical Corporation


---
---

Exhibit 13 (a)

CERTIFICATION PURSUANT TO18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Paul Averback, President and CEO of Nymox Pharmaceutical Corporation, do hereby certify that, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the information contained in the Annual Report on Form 20-F for the year ended December 31, 2014 of Nymox Pharmaceutical Corporation and filed with the Securities and Exchange Commission, fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934 and the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Nymox Pharmaceutical Corporation. Date: March 31, 2015 /s/ Paul AverbackPaul AverbackPresident and Chief Executive OfficerNymox Pharmaceutical Corporation


---
STATE of North Carolina v. Terrance L. JAMES.

No. 536P00-3.

Supreme Court of North Carolina.

October 6, 2005.

Richard Slipsky, Assistant Attorney General, William C. Young, District Attorney, for State.

*501The following order has been entered on the motion filed on the 17th day of August 2005 by Defendant to proceed without prepayment of fees and affidavit:

"Motion Allowed by order of the Court in conference this the 6th day of October 2005."